1. Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders
- Author
-
Eoin P. Flanagan, Benjamin Greenberg, Olga Ciccarelli, Olaf Stüve, Jean-Philippe Ranjeva, Maria Pia Sormani, Regina Schlaerger, Myla D. Goldman, Jeffrey A. Cohen, Emmanuelle Waubant, Franz Fazekas, Ellen M. Mowry, Daniel S. Reich, Frederik Barkhof, Hans Lassmann, Anthony Traboulsee, Sandra Vukusic, Mar Tintoré, Bernard M. J. Uitdehaag, Anke Henning, Daniel Pelletier, Alan J. Thompson, Junqian Xu, Jorge Correale, Burkhard Becher, Stephen Reingold, Nicola De Stefano, Bruce F. Bebo, Izlem Izbudak, Claudia Chien, Stephen C. Reingold, Steven Galetta, Claudia Gandini Wheeler-Kingshott, Sebastien Ourselin, Alex Rovira, Mark S. Freedman, Brenda Banwell, Aaron E. Miller, Xavier Montalban, Cornelia Laule, Claudia F. Lucchinetti, Giancarlo Comi, Peter A. Calabresi, Hans-Peter Hartung, Maria Trojano, Ludwig Kappos, Bernhard Hemmer, Bruce D. Trapp, Brian G. Weinshenker, Kazuo Fujihara, Tanuja Chitnis, Jérôme De Seze, Francois Bethoux, Per Soelberg Sørensen, Fred D. Lublin, Alexander U. Brandt, Carsten Lukas, Wallace J Brownlee, Maria Pia Amato, Jeremy Chatway, David Miller, Friedemann Paul, Maria A. Rocca, Ruth Ann Marrie, Michael J. Levy, University of Pennsylvania, VU University Medical Center [Amsterdam], University College of London [London] (UCL), Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Departamento de Neurologia, Instituto de Investigaciones Neurológicas 'Dr. Raul Carrea', Instituto de Investigaciones Neurológicas 'Dr. Raul Carrea', Service de Neurologie [Strasbourg], CHU Strasbourg-Hopital Civil, Dept. of Neurological and Behavioural Sciences, Siena, Department of Neurology [Austria], Medical University Graz, Ottawa Hospital Research Institute [Ottawa] (OHRI), Tohoku University Graduate School of Medicine, Munich Cluster of Systems Neurology (SyNery), Clinical Neuroimmunology, Department of Biomedicine, University of Basel, Basel, Matière et Systèmes Complexes (MSC), Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), St. Josef Hospital, Ruhr-University Bochum, Vall Hebron Research Institute (VHIR), Translational imaging group [London] (TIG), Centre for Medical Image Computing (CMIC), University College of London [London] (UCL)-University College of London [London] (UCL)-Department of Medical Physics and Biomedical Engineering (UCL), Max Delbrueck Centre for Molecular Medicine, Departments of Neurology and Immunobiology [Yale], Yale School of Medicine [New Haven, Connecticut] (YSM), Centre de résonance magnétique biologique et médicale (CRMBM), Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Centre National de la Recherche Scientifique (CNRS), Centre d'Exploration Métabolique par Résonance Magnétique [Hôpital de la Timone - APHM] (CEMEREM), Hôpital de la Timone [CHU - APHM] (TIMONE)-Centre de résonance magnétique biologique et médicale (CRMBM), Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Centre National de la Recherche Scientifique (CNRS), Aix Marseille Université (AMU), Centre National de la Recherche Scientifique (CNRS), National Institutes of Health [Bethesda] (NIH), Vall d'Hebron University Hospital [Barcelona], Dept. of Neurology, University Hospital Rigshospitalet, Centre d'Esclerosi Múltiple de Catalunya (CemCat), Division of Geriatric Medicine, University of British Columbia (UBC), Service de Neurologie [Lyon], CHU Lyon, Department of Neurology, University of California [San Francisco] (UC San Francisco), University of California (UC)-University of California (UC), NMR Research Unit [London], Institute of Neurology [London], University College of London [London] (UCL)-University College of London [London] (UCL), Icahn School of Medicine at Mount Sinai [New York] (MSSM), University of Pennsylvania [Philadelphia], Matière et Systèmes Complexes (MSC (UMR_7057)), Centre National de la Recherche Scientifique (CNRS)-Université Paris Diderot - Paris 7 (UPD7), Yale University School of Medicine, Centre d'Exploration Métabolique par Résonance Magnétique [Hôpital de la Timone - AP-HM] (CEMEREM), Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Centre National de la Recherche Scientifique (CNRS)- Hôpital de la Timone [CHU - APHM] (TIMONE), University of California [San Francisco] (UCSF), and University of California-University of California
- Subjects
0301 basic medicine ,Pediatrics ,medicine.medical_specialty ,Multiple Sclerosis ,[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging ,Spinal cord involvement ,03 medical and health sciences ,Myelopathy ,0302 clinical medicine ,medicine ,Humans ,Pathological ,ComputingMilieux_MISCELLANEOUS ,business.industry ,Multiple sclerosis ,Neuromyelitis Optica ,Clinical course ,medicine.disease ,Spinal cord ,3. Good health ,Clinical trial ,030104 developmental biology ,medicine.anatomical_structure ,Spinal Cord ,Neuromyelitis Optica Spectrum Disorders ,Neurology (clinical) ,business ,030217 neurology & neurosurgery - Abstract
Spinal cord involvement is an important cause of disability in patients with multiple sclerosis or neuromyelitis optica spectrum disorders (NMOSDs). Multiple sclerosis and NMOSDs can be distinguished from other disorders that cause myelopathy by results from laboratory and radiological investigations. However, limitations in the sensitivity and specificity of spinal cord imaging and poor correlation with disability megasures have impeded the understanding of the relationship between spinal cord involvement and clinical manifestations. Nevertheless, studies of the pathological features of multiple sclerosis and NMOSDs have shown that quantitatively different mechanisms lead to differences in clinical course and pattern of accrual of permanent disability in the two disorders. Better understanding of these mechanisms is necessary to develop more informative clinical measures, electrophysiological methods, fluid biomarkers, and imaging techniques to detect and monitor spinal cord involvement in the diagnosis and management of patients with multiple sclerosis or NMOSDs, and as outcome measures in clinical trials.
- Published
- 2019